Crystagen
Quick summary
A short-peptide bioregulator from the short-peptide bioregulator research tradition, studied mainly in immune-cell models. Research focus: short-peptide bioregulator research and immune cell models. SRP's starting dose for this compound is still pending.
Overview
A short-peptide bioregulator from the short-peptide bioregulator research tradition, studied mainly in immune-cell models.
Looking for research material? Simple Research Peptides lists Crystagen 20mg for laboratory research use.
Mechanism
Short bioregulator peptides (2–4 amino acids) are proposed to enter cells, interact with DNA or histones, and adjust tissue-specific gene expression. Most of the evidence comes from cell and animal studies by a small number of research groups.
Research areas
- short-peptide bioregulator research
- immune cell models
Storage & reconstitution
Supplied as a freeze-dried (lyophilized) powder in a sealed vial. Unopened vials are generally kept cold and away from light. Labs usually reconstitute it with bacteriostatic or sterile water, letting the liquid run down the vial wall and swirling gently instead of shaking. The solution is then kept refrigerated.
Recommended starting dose (low and slow)
| Starting dose | Pending - to be added by SRP |
|---|---|
| Frequency | Pending - to be added by SRP |
| Reconstitution | Pending - to be added by SRP |
Route and timing
Route: Subcutaneous injection after reconstitution is the route most often described in research protocols.
Timing: Pending - to be added by SRP
Cycle length and repeat
Pending - to be added by SRP
Half-life
Approximate, for Bobby's review: Not well characterized in published research.
Side effects
Pending - to be added by SRP
Suggested bloodwork and monitoring
Draft, for Bobby's review: CBC and comprehensive metabolic panel (kidney and liver function, electrolytes) before starting and again after a few weeks.
Cautions
Pending - to be added by SRP
Reconstitution calculator
Math aid only. It converts the numbers you enter; it is not dosing advice. For research use only. Prefilled with this page's vial size, reconstitution and low-and-slow starting dose where known; change any value.
Frequently asked questions
What is Crystagen studied for?
In research it is studied for short-peptide bioregulator research and immune cell models. Short bioregulator peptides (2–4 amino acids) are proposed to enter cells, interact with DNA or histones, and adjust tissue-specific gene expression.
How is Crystagen given in research?
Subcutaneous injection after reconstitution is the route most often described in research protocols. SRP has not yet published a frequency for this compound.
What amount should a researcher start with?
SRP has not yet published a starting dose for Crystagen. Contact SRP before starting any research protocol, and do not guess.
Related peptides
Last updated: October 19, 2026